[{"address1": "25420 Kuykendahl Road", "address2": "Suite B300", "city": "Tomball", "state": "TX", "zip": "77375", "country": "United States", "phone": "281 675 2421", "website": "https://www.ricebrantech.com", "industry": "Packaged Foods", "sector": "Consumer Defensive", "longBusinessSummary": "RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company in the United States and internationally. It focuses on development, production, and marketing of products derived from rice and other small and ancient grains for the nutraceutical, healthy food, companion animal, and equine feed categories. The company converts raw rice bran into stabilized rice bran (SRB) and high value SRB derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious, carbohydrate, and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and ProRyza products, which includes derivatives composed of protein and protein/fiber blends. It serves food and animal nutrition manufacturers, wholesalers, and retailers. The company was formerly known as NutraCea and changed its name to RiceBran Technologies in October 2012. RiceBran Technologies was founded in 2000 and is headquartered in Tomball, Texas.", "fullTimeEmployees": 94, "companyOfficers": [{"maxAge": 1, "name": "Mr. Eric  Tompkins", "age": 62, "title": "Executive Chairman", "yearBorn": 1961, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. William J. Keneally", "age": 60, "title": "Interim CFO & Secretary", "yearBorn": 1963, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rani Madhavapeddi Patel", "title": "Chief Science Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sherry  Rhoads", "title": "Vice President of Compliance, Regulatory & External Affairs", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joseph  Gutman M.D.", "title": "Strategic Consultant & Member of Medical Advisory Board", "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 4, "previousClose": 0.15, "open": 0.15, "dayLow": 0.15, "dayHigh": 0.21, "regularMarketPreviousClose": 0.15, "regularMarketOpen": 0.15, "regularMarketDayLow": 0.15, "regularMarketDayHigh": 0.21, "beta": 0.464, "forwardPE": -1.6372727, "volume": 21727, "regularMarketVolume": 21727, "averageVolume": 29630, "averageVolume10days": 9080, "averageDailyVolume10Day": 9080, "bidSize": 1000, "askSize": 800, "marketCap": 1713244, "fiftyTwoWeekLow": 0.07, "fiftyTwoWeekHigh": 1.27, "priceToSalesTrailing12Months": 0.043507643, "fiftyDayAverage": 0.1666, "twoHundredDayAverage": 0.5007, "currency": "USD", "enterpriseValue": 5586911, "profitMargins": -0.40175, "floatShares": 6380386, "sharesOutstanding": 9512740, "sharesShort": 79824, "sharesShortPriorMonth": 115146, "sharesShortPreviousMonthDate": 1694736000, "dateShortInterest": 1697155200, "sharesPercentSharesOut": 0.0121, "heldPercentInsiders": 0.03907, "heldPercentInstitutions": 0.25867, "shortRatio": 3.4, "shortPercentOfFloat": 0.0123000005, "bookValue": -0.13, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -7550000, "trailingEps": -1.16, "forwardEps": -0.11, "lastSplitFactor": "1:200", "lastSplitDate": 1384732800, "enterpriseToRevenue": 0.142, "enterpriseToEbitda": -1.102, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "RIBT", "underlyingSymbol": "RIBT", "shortName": "RiceBran Technologies", "longName": "RiceBran Technologies", "firstTradeDateEpochUtc": 1065015000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "26482c63-cd0d-389d-a7fe-8666ab85c842", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.1801, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 466000, "totalCashPerShare": 0.049, "ebitda": -5069000, "totalDebt": 4551000, "quickRatio": 0.307, "currentRatio": 0.41, "totalRevenue": 39378000, "revenuePerShare": 5.992, "returnOnAssets": -0.22588, "returnOnEquity": -1.2158799, "freeCashflow": 3916000, "operatingCashflow": -1157000, "revenueGrowth": -0.268, "grossMargins": -0.00736, "ebitdaMargins": -0.12873, "operatingMargins": -0.35619, "financialCurrency": "USD", "trailingPegRatio": null}]